Clinical Trial: Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Clinical Trial: Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Sponsor and Collaborators
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
National Cancer Institute (NCI)

Contact
Contact: Clinical Trials Office – Cincinnati Children’s Hospital Medica
(513)-636-2799

Principal Investigator
Thomas E. Olencki, DO
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

ClinicalTrials.gov Identifier
NCT00563290